QSAM Biosciences Signs Term Sheet To Be Acquired By Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration And Option Fee >QSAM
QSAM Biosciences Signs Term Sheet To Be Acquired By Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration And Option Fee >QSAM
QSAM Biosciences 簽署將被 Telix Pharmicals 收購的條款表；收到 200 萬美元的收盤前合作費和期權費 >QSAM
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊